❌

Normal view

Streamlining evidence based clinical recommendations with large language models

arXiv:2505.10282v2 Announce Type: replace-cross Abstract: Clinical evidence underpins informed healthcare decisions, yet integrating it into real-time practice remains challenging due to intensive workloads, complex procedures, and time constraints. This study presents Quicker, an LLM-powered system that automates evidence synthesis and generates clinical recommendations following standard guideline development workflows. Quicker delivers an end-to-end pipeline from clinical questions to recommendations and supports customized decision-making through integrated tools and interactive interfaces. To evaluate how closely Quicker can reproduce guideline development processes, we constructed Q2CRBench-3, a benchmark derived from guideline development records for three diseases. Experiments show that Quicker produces precise question decomposition, expert-aligned retrieval, and near-comprehensive screening. Quicker assistance improved the accuracy of extracted study data, and its recommendations were more comprehensive and coherent than clinician-written ones. In system-level testing, Quicker working with one participant reduced recommendation development to 20-40 min. Overall, the findings demonstrate Quicker's potential to enhance the speed and reliability of evidence-based clinical decision-making.

CliCARE: Grounding Large Language Models in Clinical Guidelines for Decision Support over Longitudinal Cancer Electronic Health Records

arXiv:2507.22533v2 Announce Type: replace-cross Abstract: Large Language Models (LLMs) hold significant promise for improving clinical decision support and reducing physician burnout by synthesizing complex, longitudinal cancer Electronic Health Records (EHRs). However, their implementation in this critical field faces three primary challenges: the inability to effectively process the extensive length and fragmented nature of patient records for accurate temporal analysis; a heightened risk of clinical hallucination, as conventional grounding techniques such as Retrieval-Augmented Generation (RAG) do not adequately incorporate process-oriented clinical guidelines; and unreliable evaluation metrics that hinder the validation of AI systems in oncology. To address these issues, we propose CliCARE, a framework for Grounding Large Language Models in Clinical Guidelines for Decision Support over Longitudinal Cancer Electronic Health Records. The framework operates by transforming unstructured, longitudinal EHRs into patient-specific Temporal Knowledge Graphs (TKGs) to capture long-range dependencies, and then grounding the decision support process by aligning these real-world patient trajectories with a normative guideline knowledge graph. This approach provides oncologists with evidence-grounded decision support by generating a high-fidelity clinical summary and an actionable recommendation. We validated our framework using large-scale, longitudinal data from a private Chinese cancer dataset and the public English MIMIC-IV dataset. In these settings, CliCARE significantly outperforms baselines, including leading long-context LLMs and Knowledge Graph-enhanced RAG methods. The clinical validity of our results is supported by a robust evaluation protocol, which demonstrates a high correlation with assessments made by oncologists.

Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making

Cancers (Basel). 2025 Dec 27;18(1):94. doi: 10.3390/cancers18010094.

ABSTRACT

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor long-term survival despite advances in surgical techniques, systemic therapies, and perioperative management. High rates of systemic recurrence following curative-intent resection suggest that many patients harbor minimal residual disease (MRD), microscopic tumor burden that persists postoperatively and remains undetectable by conventional diagnostic tools. Recent advances in liquid biopsy technologies, particularly circulating tumor DNA (ctDNA) analysis, alongside detailed characterization of the PDAC mutational landscape, offer a promising non-invasive approach for MRD detection. Emerging evidence indicates that MRD status can serve as a sensitive prognostic biomarker, identify patients at high risk of relapse, and guide personalized perioperative therapy, including optimization of adjuvant treatment. This review summarizes current knowledge on the biology and detection of MRD in PDAC, its implications for perioperative risk stratification and treatment decision-making, and discusses future directions for integrating MRD assessment into clinical practice to enable more precise, individualized patient management.

PMID:41514607 | PMC:PMC12784771 | DOI:10.3390/cancers18010094

  • ✇AI News
  • Autonomy without accountability: The real AI risk Chad Harwood-Jones
    If you have ever taken a self-driving Uber through downtown LA, you might recognise the strange sense of uncertainty that settles in when there is no driver and no conversation, just a quiet car making assumptions about the world around it. The journey feels fine until the car misreads a shadow or slows abruptly for something harmless. In that moment you see the real issue with autonomy. It does not panic when it should, and that gap between confidence and judgement is where trust is either earn
     

Autonomy without accountability: The real AI risk

9 January 2026 at 22:44

If you have ever taken a self-driving Uber through downtown LA, you might recognise the strange sense of uncertainty that settles in when there is no driver and no conversation, just a quiet car making assumptions about the world around it. The journey feels fine until the car misreads a shadow or slows abruptly for something harmless. In that moment you see the real issue with autonomy. It does not panic when it should, and that gap between confidence and judgement is where trust is either earned or lost. Much of today’s enterprise AI feels remarkably similar. It is competent without being confident, and efficient without being empathetic, which is why the deciding factor in every successful deployment is no longer computing power but trust.

The MLQ State of AI in Business 2025 [PDF] report puts a sharp number on this. 95% of early AI pilots fail to produce measurable ROI, not because the technology is weak but because it is mismatched to the problems organisations are trying to solve. The pattern repeats itself in industries. Leaders get uneasy when they can’t tell if the output is right, teams are unsure whether dashboards can be trusted, and customers quickly lose patience when an interaction feels automated rather than supported. Anyone who has been locked out of their bank account while the automated recovery system insists their answers are wrong knows how quickly confidence evaporates.

Klarna remains the most publicised example of large-scale automation in action. The company has now halved its workforce since 2022 and says internal AI systems are performing the work of 853 full-time roles, up from 700 earlier this year. Revenues have risen 108%, while average employee compensation has increased 60%, funded in part by those operational gains. Yet the picture is more complicated. Klarna still reported a 95 million dollar quarterly loss, and its CEO has warned that further staff reductions are likely. It shows that automation alone does not create stability. Without accountability and structure, the experience breaks down long before the AI does. As Jason Roos, CEO of CCaaS provider Cirrus, puts it, “Any transformation that unsettles confidence, inside or outside the business, carries a cost you cannot ignore. it can leave you worse off.”

We have already seen what happens when autonomy runs ahead of accountability. The UK’s Department for Work and Pensions used an algorithm that wrongly flagged around 200,000 housing-benefit claims as potentially fraudulent, even though the majority were legitimate. The problem wasn’t the technology. It was the absence of clear ownership over its decisions. When an automated system suspends the wrong account, rejects the wrong claim or creates unnecessary fear, the issue is never just “why did the model misfire?” It’s “who owns the outcome?” Without that answer, trust becomes fragile.

“The missing step is always readiness,” says Roos. “If the process, the data and the guardrails aren’t in place, autonomy doesn’t accelerate performance, it amplifies the weaknesses. Accountability has to come first. Start with the outcome, find where effort is being wasted, check your readiness and governance, and only then automate. Skip those steps and accountability disappears just as fast as the efficiency gains arrive.”

Part of the problem is an obsession with scale without the grounding that makes scale sustainable. Many organisations push toward autonomous agents that can act decisively, yet very few pause to consider what happens when those actions drift outside expected boundaries. The Edelman Trust Barometer [PDF] shows a steady decline in public trust in AI over the past five years, and a joint KPMG and University of Melbourne study found that workers prefer more human involvement in almost half the tasks examined. The findings reinforce a simple point. Trust rarely comes from pushing models harder. It comes from people taking the time to understand how decisions are made, and from governance that behaves less like a brake pedal and more like a steering wheel.

The same dynamics appear on the customer side. PwC’s trust research reveals a wide gulf between perception and reality. Most executives believe customers trust their organisation, while only a minority of customers agree. Other surveys show that transparency helps to close this gap, with large majorities of consumers wanting clear disclosure when AI is used in service experiences. Without that clarity, people do not feel reassured. They feel misled, and the relationship becomes strained. Companies that communicate openly about their AI use are not only protecting trust but also normalising the idea that technology and human support can co-exist.

Some of the confusion stems from the term “agentic AI” itself. Much of the market treats it as something unpredictable or self-directing, when in reality it is workflow automation with reasoning and recall. It is a structured way for systems to make modest decisions inside parameters designed by people. The deployments that scale safely all follow the same sequence. They start with the outcome they want to improve, then look at where unnecessary effort sits in the workflow, then assess whether their systems and teams are ready for autonomy, and only then choose the technology. Reversing that order does not speed anything up. It simply creates faster mistakes. As Roos says, AI should expand human judgement, not replace it.

All of this points toward a wider truth. Every wave of automation eventually becomes a social question rather than a purely technical one. Amazon built its dominance through operational consistency, but it also built a level of confidence that the parcel would arrive. When that confidence dips, customers move on. AI follows the same pattern. You can deploy sophisticated, self-correcting systems, but if the customer feels tricked or misled at any point, the trust breaks. Internally, the same pressures apply. The KPMG global study [PDF] highlights how quickly employees disengage when they do not understand how decisions are made or who is accountable for them. Without that clarity, adoption stalls.

As agentic systems take on more conversational roles, the emotional dimension becomes even more significant. Early reviews of autonomous chat interactions show that people now judge their experience not only by whether they were helped but also by whether the interaction felt attentive and respectful. A customer who feels dismissed rarely keeps the frustration to themselves. The emotional tone of AI is becoming a genuine operational factor, and systems that cannot meet that expectation risk becoming liabilities.

The difficult truth is that technology will continue to move faster than people’s instinctive comfort with it. Trust will always lag behind innovation. That is not an argument against progress. It is an argument for maturity. Every AI leader should be asking whether they would trust the system with their own data, whether they can explain its last decision in plain language, and who steps in when something goes wrong. If those answers are unclear, the organisation is not leading transformation. It is preparing an apology.

Roos puts it simply, “Agentic AI is not the concern. Unaccountable AI is.”

When trust goes, adoption goes, and the project that looked transformative becomes another entry in the 95% failure rate. Autonomy is not the enemy. Forgetting who is responsible is. The organisations that keep a human hand on the wheel will be the ones still in control when the self-driving hype eventually fades.

The post Autonomy without accountability: The real AI risk appeared first on AI News.

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-z

Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04171-y

In a randomized, double-blind, placebo-controlled trial comparing autologous mRNA-engineered BCMA-targeting CAR T cell therapy versus placebo in patients with generalized myasthenia gravis, a significantly higher percentage of patients exhibited a reduction in disease activity in the treatment arm than in the placebo arm.

Sci-Reasoning: A Dataset Decoding AI Innovation Patterns

arXiv:2601.04577v1 Announce Type: new Abstract: While AI innovation accelerates rapidly, the intellectual process behind breakthroughs -- how researchers identify gaps, synthesize prior work, and generate insights -- remains poorly understood. The lack of structured data on scientific reasoning hinders systematic analysis and development of AI research agents. We introduce Sci-Reasoning, the first dataset capturing the intellectual synthesis behind high-quality AI research. Using community-validated quality signals and an LLM-accelerated, human-verified pipeline, we trace Oral and Spotlight papers across NeurIPS, ICML, and ICLR (2023-2025) to its key predecessors, articulating specific reasoning links in a structured format. Our analysis identifies 15 distinct thinking patterns, with three dominant strategies accounting for 52.7%: Gap-Driven Reframing (24.2%), Cross-Domain Synthesis (18.0%), and Representation Shift (10.5%). The most powerful innovation recipes combine multiple patterns: Gap-Driven Reframing + Representation Shift, Cross-Domain Synthesis + Representation Shift, and Gap-Driven Reframing + Cross-Domain Synthesis. This dataset enables quantitative studies of scientific progress and provides structured reasoning trajectories for training the next generation AI research agents.

Beyond Monolithic Architectures: A Multi-Agent Search and Knowledge Optimization Framework for Agentic Search

arXiv:2601.04703v1 Announce Type: new Abstract: Agentic search has emerged as a promising paradigm for complex information seeking by enabling Large Language Models (LLMs) to interleave reasoning with tool use. However, prevailing systems rely on monolithic agents that suffer from structural bottlenecks, including unconstrained reasoning outputs that inflate trajectories, sparse outcome-level rewards that complicate credit assignment, and stochastic search noise that destabilizes learning. To address these challenges, we propose \textbf{M-ASK} (Multi-Agent Search and Knowledge), a framework that explicitly decouples agentic search into two complementary roles: Search Behavior Agents, which plan and execute search actions, and Knowledge Management Agents, which aggregate, filter, and maintain a compact internal context. This decomposition allows each agent to focus on a well-defined subtask and reduces interference between search and context construction. Furthermore, to enable stable coordination, M-ASK employs turn-level rewards to provide granular supervision for both search decisions and knowledge updates. Experiments on multi-hop QA benchmarks demonstrate that M-ASK outperforms strong baselines, achieving not only superior answer accuracy but also significantly more stable training dynamics.\footnote{The source code for M-ASK is available at https://github.com/chenyiqun/M-ASK.}

Decision-Aware Trust Signal Alignment for SOC Alert Triage

arXiv:2601.04486v1 Announce Type: cross Abstract: Detection systems that utilize machine learning are progressively implemented at Security Operations Centers (SOCs) to help an analyst to filter through high volumes of security alerts. Practically, such systems tend to reveal probabilistic results or confidence scores which are ill-calibrated and hard to read when under pressure. Qualitative and survey based studies of SOC practice done before reveal that poor alert quality and alert overload greatly augment the burden on the analyst, especially when tool outputs are not coherent with decision requirements, or signal noise. One of the most significant limitations is that model confidence is usually shown without expressing that there are asymmetric costs in decision making where false alarms are much less harmful than missed attacks. The present paper presents a decision-sensitive trust signal correspondence scheme of SOC alert triage. The framework combines confidence that has been calibrated, lightweight uncertainty cues, and cost-sensitive decision thresholds into coherent decision-support layer, instead of making changes to detection models. To enhance probabilistic consistency, the calibration is done using the known post-hoc methods and the uncertainty cues give conservative protection in situations where model certainty is low. To measure the model-independent performance of the suggested model, we apply the Logistic Regression and the Random Forest classifiers to the UNSW-NB15 intrusion detection benchmark. According to simulation findings, false negatives are greatly amplified by the presence of misaligned displays of confidence, whereas cost weighted loss decreases by orders of magnitude between models with decision aligned trust signals. Lastly, we describe a human-in-the-loop study plan that would allow empirically assessing the decision-making of the analysts with aligned and misaligned trust interfaces.

PILOT-Bench: A Benchmark for Legal Reasoning in the Patent Domain with IRAC-Aligned Classification Tasks

arXiv:2601.04758v1 Announce Type: cross Abstract: The Patent Trial and Appeal Board (PTAB) of the USPTO adjudicates thousands of ex parte appeals each year, requiring the integration of technical understanding and legal reasoning. While large language models (LLMs) are increasingly applied in patent and legal practice, their use has remained limited to lightweight tasks, with no established means of systematically evaluating their capacity for structured legal reasoning in the patent domain. In this work, we introduce PILOT-Bench, the first PTAB-centric benchmark that aligns PTAB decisions with USPTO patent data at the case-level and formalizes three IRAC-aligned classification tasks: Issue Type, Board Authorities, and Subdecision. We evaluate a diverse set of closed-source (commercial) and open-source LLMs and conduct analyses across multiple perspectives, including input-variation settings, model families, and error tendencies. Notably, on the Issue Type task, closed-source models consistently exceed 0.75 in Micro-F1 score, whereas the strongest open-source model (Qwen-8B) achieves performance around 0.56, highlighting a substantial gap in reasoning capabilities. PILOT-Bench establishes a foundation for the systematic evaluation of patent-domain legal reasoning and points toward future directions for improving LLMs through dataset design and model alignment. All data, code, and benchmark resources are available at https://github.com/TeamLab/pilot-bench.

Smart IoT-Based Wearable Device for Detection and Monitoring of Common Cow Diseases Using a Novel Machine Learning Technique

arXiv:2601.04761v1 Announce Type: cross Abstract: Manual observation and monitoring of individual cows for disease detection present significant challenges in large-scale farming operations, as the process is labor-intensive, time-consuming, and prone to reduced accuracy. The reliance on human observation often leads to delays in identifying symptoms, as the sheer number of animals can hinder timely attention to each cow. Consequently, the accuracy and precision of disease detection are significantly compromised, potentially affecting animal health and overall farm productivity. Furthermore, organizing and managing human resources for the manual observation and monitoring of cow health is a complex and economically demanding task. It necessitates the involvement of skilled personnel, thereby contributing to elevated farm maintenance costs and operational inefficiencies. Therefore, the development of an automated, low-cost, and reliable smart system is essential to address these challenges effectively. Although several studies have been conducted in this domain, very few have simultaneously considered the detection of multiple common diseases with high prediction accuracy. However, advancements in Internet of Things (IoT), Machine Learning (ML), and Cyber-Physical Systems have enabled the automation of cow health monitoring with enhanced accuracy and reduced operational costs. This study proposes an IoT-enabled Cyber-Physical System framework designed to monitor the daily activities and health status of cow. A novel ML algorithm is proposed for the diagnosis of common cow diseases using collected physiological and behavioral data. The algorithm is designed to predict multiple diseases by analyzing a comprehensive set of recorded physiological and behavioral features, enabling accurate and efficient health assessment.

Belief in Authority: Impact of Authority in Multi-Agent Evaluation Framework

arXiv:2601.04790v1 Announce Type: cross Abstract: Multi-agent systems utilizing large language models often assign authoritative roles to improve performance, yet the impact of authority bias on agent interactions remains underexplored. We present the first systematic analysis of role-based authority bias in free-form multi-agent evaluation using ChatEval. Applying French and Raven's power-based theory, we classify authoritative roles into legitimate, referent, and expert types and analyze their influence across 12-turn conversations. Experiments with GPT-4o and DeepSeek R1 reveal that Expert and Referent power roles exert stronger influence than Legitimate power roles. Crucially, authority bias emerges not through active conformity by general agents, but through authoritative roles consistently maintaining their positions while general agents demonstrate flexibility. Furthermore, authority influence requires clear position statements, as neutral responses fail to generate bias. These findings provide key insights for designing multi-agent frameworks with asymmetric interaction patterns.

Atlas 2 -- Foundation models for clinical deployment

arXiv:2601.05148v1 Announce Type: cross Abstract: Pathology foundation models substantially advanced the possibilities in computational pathology -- yet tradeoffs in terms of performance, robustness, and computational requirements remained, which limited their clinical deployment. In this report, we present Atlas 2, Atlas 2-B, and Atlas 2-S, three pathology vision foundation models which bridge these shortcomings by showing state-of-the-art performance in prediction performance, robustness, and resource efficiency in a comprehensive evaluation across eighty public benchmarks. Our models were trained on the largest pathology foundation model dataset to date comprising 5.5 million histopathology whole slide images, collected from three medical institutions Charit\'e - Universt\"atsmedizin Berlin, LMU Munich, and Mayo Clinic.

PsychEval: A Multi-Session and Multi-Therapy Benchmark for High-Realism AI Psychological Counselor

arXiv:2601.01802v3 Announce Type: replace Abstract: To develop a reliable AI for psychological assessment, we introduce \texttt{PsychEval}, a multi-session, multi-therapy, and highly realistic benchmark designed to address three key challenges: \textbf{1) Can we train a highly realistic AI counselor?} Realistic counseling is a longitudinal task requiring sustained memory and dynamic goal tracking. We propose a multi-session benchmark (spanning 6-10 sessions across three distinct stages) that demands critical capabilities such as memory continuity, adaptive reasoning, and longitudinal planning. The dataset is annotated with extensive professional skills, comprising over 677 meta-skills and 4577 atomic skills. \textbf{2) How to train a multi-therapy AI counselor?} While existing models often focus on a single therapy, complex cases frequently require flexible strategies among various therapies. We construct a diverse dataset covering five therapeutic modalities (Psychodynamic, Behaviorism, CBT, Humanistic Existentialist, and Postmodernist) alongside an integrative therapy with a unified three-stage clinical framework across six core psychological topics. \textbf{3) How to systematically evaluate an AI counselor?} We establish a holistic evaluation framework with 18 therapy-specific and therapy-shared metrics across Client-Level and Counselor-Level dimensions. To support this, we also construct over 2,000 diverse client profiles. Extensive experimental analysis fully validates the superior quality and clinical fidelity of our dataset. Crucially, \texttt{PsychEval} transcends static benchmarking to serve as a high-fidelity reinforcement learning environment that enables the self-evolutionary training of clinically responsible and adaptive AI counselors.

Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study

Background: Structured medication reviews (SMRs) are an essential component of medication optimization, especially for patients with multimorbidity and polypharmacy. However, the process remains challenging due to the complexities of patient data, time constraints, and the need for coordination among health care professionals (HCPs). This study explores HCPs’ perspectives on the integration of artificial intelligence (AI)–assisted tools to enhance the SMR process, with a focus on the potential benefits of and barriers to adoption. Objective: This study aims to identify the key user requirements for AI-assisted tools to improve the efficiency and effectiveness of SMRs, specifically for patients with multimorbidity, complex polypharmacy, and frailty. Methods: A qualitative study was conducted involving focus groups and semistructured interviews with HCPs and patients in the United Kingdom. Participants included physicians, pharmacists, clinical pharmacologists, psychiatrists from primary and secondary care, a policy maker, and patients with multimorbidity. Data were analyzed using a hybrid inductive and deductive thematic analysis approach to identify themes related to AI-assisted tool functionality, workflow integration, user-interface visualization, and usability in the SMR process. Results: Four major themes emerged from the analysis: innovative AI potential, optimizing electronic patient record visualization, functionality of the AI tool for SMRs, and facilitators of and barriers to AI tool implementation. HCPs identified the potential of AI to support patient identification and prioritizing those at risk of medication-related harm. AI-assisted tools were viewed as essential in detecting prescribing gaps, drug interactions, and patient risk trajectories over time. Participants emphasized the importance of presenting patient data in an intuitive format, with a patient interface for shared decision-making. Suggestions included color-coding blood results, highlighting critical medication reviews, and providing timelines of patient medical histories. HCPs stressed the need for AI tools to integrate seamlessly with existing electronic patient record systems and provide actionable insights without overwhelming users with excessive notifications or “pop-up” alerts. Factors influencing the uptake of AI-assisted tools included the need for user-friendly design, evidence of tool effectiveness (though some were skeptical about the predictive accuracy of AI models), and addressing concerns around digital exclusion. Conclusions: The findings highlight the potential for AI-assisted tools to streamline and optimize the SMR process, particularly for patients with multimorbidity and complex polypharmacy. However, successful implementation depends on addressing concerns related to workflow integration, user acceptance, and evidence of effectiveness. User-centered design is crucial to ensure that AI-assisted tools support HCPs in delivering high-quality, patient-centered care while minimizing cognitive overload and alert fatigue.

Intervention in Health Misinformation Using Large Language Models for Automated Detection, Thematic Analysis, and Inoculation: Case Study on COVID-19

Background: The rapid growth of social media as an information channel has enabled the swift spread of inaccurate or false health information, significantly impacting public health. This widespread dissemination of misinformation has caused confusion, eroded trust in health authorities, led to noncompliance with health guidelines, and encouraged risky health behaviors. Understanding the dynamics of misinformation on social media is essential for devising effective public health communication strategies. Objective: This study aims to present a comprehensive and automated approach that leverages Large Language Models (LLMs) and Machine Learning (ML) techniques to detect misinformation on social media, uncover the underlying causes and themes, and generate refutation arguments, facilitating control of its spread and promoting public health outcomes by inoculating people against health misinformation. Methods: We use two datasets to train three LLMs, namely BERT, T5, and GPT-2, to classify documents into two categories: misinformation and non-misinformation. Additionally, we employ a separate dataset to identify misinformation topics. To analyze these topics, we applied three topic modeling algorithms—Latent Dirichlet Allocation (LDA), Top2Vec, and BERTopic—and selected the optimal model based on performance evaluated across three metrics. Using a prompting approach, we extract sentence-level representations for the topics to uncover their underlying themes. Finally, we design a prompt text capable of identifying misinformation themes effectively. Codes are available at https://github.com/SamiraMalek/MDIP-MDIS. Results: The trained BERT model demonstrated exceptional performance, achieving 98% accuracy in classifying misinformation and non-misinformation, with a 44% reduction in false positive rates for AI-generated misinformation. Among the three topic modeling approaches employed, BERTopic outperformed the others, achieving the highest metrics with a Coherence Value (CV) of 0.41, Normalized Pointwise Mutual Information (NPMI) of -0.086, and Inverted RBO (IRBO) of 0.99. To address the issue of unclassified documents, we developed an algorithm to assign each document to its closest topic. Additionally, we proposed a novel method using prompt engineering to generate sentence-level representations for each topic, achieving a 99.6% approval rate as "appropriate" or "somewhat appropriate" by three independent raters. We further designed a prompt text to identify themes of misinformation topics and developed another prompt capable of detecting misinformation themes with 82% accuracy. Conclusions: This study presents a comprehensive and automated approach to addressing health misinformation on social media using advanced machine learning and natural language processing techniques. By leveraging large language models (LLMs) and prompt engineering, the system effectively detects misinformation, identifies underlying themes, and provides explanatory responses to combat its spread. The proposed method was tested on an English-language COVID-19–related dataset and has not been evaluated on real-world online social media data; the experiments were conducted offline.
  • ✇STAT
  • Medicaid restrictions may lead to a million missed cancer screenings over two years: study Angus Chen
    In less than a year, new Medicaid eligibility restrictions may lead millions of people to lose coverage and then miss potentially lifesaving cancer screenings like colonoscopies or mammograms. A new analysis estimates that Americans may miss more than a million cancer screenings for colorectal, breast, or lung cancer over the two years after the new policy takes effect. “I see patients every day that come to me with cancer and are asymptomatic, but their life gets turned upside down because t
     

Medicaid restrictions may lead to a million missed cancer screenings over two years: study

9 January 2026 at 00:00

In less than a year, new Medicaid eligibility restrictions may lead millions of people to lose coverage and then miss potentially lifesaving cancer screenings like colonoscopies or mammograms. A new analysis estimates that Americans may miss more than a million cancer screenings for colorectal, breast, or lung cancer over the two years after the new policy takes effect.

“I see patients every day that come to me with cancer and are asymptomatic, but their life gets turned upside down because they are told they have cancer,” said Adrian Diaz, a surgical oncologist at the University of Chicago and one of the authors on the paper, published Thursday in JAMA Oncology. “In a positive way, we catch it early. It’s potentially treatable, curable. Seeing that number, over a million patients, who will not have that opportunity — I was taken aback.”

Read the rest…

© ASHRAF SHAZLY/AFP via Getty Images

A Web-Based Cancer Prevention Intervention for Rural Emerging Adults: Mixed Methods Development and Pilot-Testing Study

Background: The rapid growth of user-generated web-based health information increases the complexity of cancer information seeking. One promising strategy for promoting high-quality cancer information consumption is through targeted interventions that are intentionally designed to reach individuals in the web-based spaces they occupy. However, there is a paucity of evidence-based information on the best strategies for designing and implementing web-based health behavior change interventions to improve individuals’ cancer-related knowledge and prevent cancer. Objective: This study aimed to develop and pilot test a theory-based intervention via the web to reduce 6 cancer risk factors among rural emerging adults (EAs) through community-engaged research. Methods: This mixed methods evaluation describes the development of a web-based cancer prevention intervention aimed at rural EAs aged 18-26 years in the United States and delivered in Facebook private groups. The intervention was guided by behavior change theory and cocreated with EA and Stakeholder Organization Advisory Boards to ensure relevance, accessibility, and appropriateness. We report on 3 formative surveys, a pilot intervention, protocol development, and the community-engaged process for intervention development. Descriptive statistics were applied to the surveys and pilot intervention baseline results to produce means and SDs using R. Results: We developed posts (n=400) for a Facebook feed aimed at reducing 6 cancer risk behaviors (unhealthy diet, lack of physical activity, tobacco use, alcohol use, sun exposure, and human papillomavirus infection) with iterative input from the EA and stakeholder advisory boards. Formative surveys with rural EAs (n=297) and a pilot study of the intervention with this population (n=26) were conducted. In the pilot study, the intervention reached participants across rural counties, with sustained engagement (post views=1060, reactions=346, comments=72) over a one-month period. Key modifications to the intervention content and design emerged from both advisory boards, the formative surveys, and the pilot intervention, focusing on using perceived reliable sources and direct links to source material. Conclusions: This web-based cancer prevention intervention is scalable and delivers engaging, evidence-informed health information to rural EAs. We offer key insights into the design and implementation of web-based cancer prevention interventions for EAs by describing the resources, timelines, and expertise needed to design and implement the intervention. Considerations for fully engaging EA and community stakeholder partners are presented, and we discuss how their involvement resulted in modifications that strengthened the intervention. Finally, we highlight the importance of theory-based health-behavior messaging, digital messaging skillsets, and platform-tailored dissemination strategies for maximizing web-based intervention acceptability. Trial Registration: ClinicalTrials.gov NCT05618158; https://classic.clinicaltrials.gov/ct2/show/NCT05618158

Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma

Thorac Cancer. 2026 Jan;17(1):e70244. doi: 10.1111/1759-7714.70244.

ABSTRACT

MAIN PROBLEM: The treatment and prognosis of lung adenocarcinoma (LUAD) remain challenging. The study aimed to identify prognostic genes and construct a prognostic model for LUAD.

METHODS: After identifying malignant alveolar type II (AT2) cells using InferCNV, we applied CytoTRACE, pseudo-time analysis, Mendelian randomization (MR), and univariate Cox regression analysis to identify prognostic genes. A prognostic model was then developed using an optimized subset of these genes, selected through the least absolute shrinkage and selection operator (LASSO) algorithm. Further analyses included Gene Ontology enrichment analysis and the construction of a protein-protein interaction (PPI) network.

RESULTS: Pseudo-time analysis identified 3526 dynamically expressed genes during malignant AT2 cell dedifferentiation. Subsequent multi-omics integration refined the gene selection, yielding four prognostic genes for the final predictive model. The resulting model achieved area under the receiver operating characteristic (ROC) curve (AUC) values of 0.649, 0.675, and 0.654 for predicting 1, 2, and 3-year overall survival (OS) in the training set, respectively, and was successfully validated in two external cohorts at the corresponding time points. Moreover, survival analysis demonstrated that patients in the high-risk group had significantly poorer OS than those in the low-risk group, both in the training set and the validation sets (p < 0.01).

CONCLUSIONS: The study developed a novel signature based on genes dynamically expressed during malignant AT2 cell dedifferentiation, capable of predicting the prognosis of LUAD patients, and offered four accurate prognostic biomarkers (ADM, MARK4, PARVA, and RPS6KA1).

PMID:41500831 | DOI:10.1111/1759-7714.70244

❌